- Home
- » Tags
- » Treprostinil
Top View
- Prostanoid EP2 Receptors Are Up-Regulated in Human Pulmonary Arterial Hypertension: a Key Anti-Proliferative Target for Treprostinil in Smooth Muscle Cells
- Recent Advances in Targeting the Prostacyclin Pathway in Pulmonary Arterial Hypertension
- Uses and Administration Adverse Effects and Precautions Interactions
- Orenitram® (Treprostinil) Extended-Release Tablets Referral Form
- The Research, the Impact of Inhaled Treprostinil on Patient Lung Function
- Label: REMODULIN (Treprostinil) Injection, for Subcutaneous Or Intravenous
- 1628.Full-Text.Pdf
- Interactions Drug
- Treprostinil Sodium (Inhalation Use) for the Treatment of Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension
- Customs Tariff - Schedule
- Identification of Therapeutic Drugs Against COVID-19 Through Computational Investigation on Drug Repurposing and Structural Modification
- Trepulmix, INN-Treprostinil
- Pharmacological Interventions for the Prevention of Fetal Growth Restriction
- Tyvaso Inhalation Solution 醫療科技評估報告 「藥物納入全民健康保險給付建議書-藥品專用」資料摘要
- Treprostinil Sodium Inhalation for Patients At-High Risk for ARDS: Effect on Oxygenation and Disease-Related Biomarkers
- Predicting Drug Responses by Propagating Interactions Through Text-Enhanced Drug-Gene Networks
- Project SCYLLA
- Systemic Glucocorticoids in the Treatment of COVID-19 and Risks of Adverse Outcomes in COVID-19 Patients in the Primary and Secondary Care Setting
- Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
- The Role of Prostacyclin and Prostaglandin Analogs
- Medication Safety and High Alert Medications Objectives
- Customs Tariff - Schedule
- Beraprost Modified Release in Addition to Treprostinil for Pulmonary Arterial Hypertension
- Summary of Product Characteristics 1. Name Of
- Rottlerin for the Treatment of Pulmonary Hypertension and Related Diseases and Disorders
- Supplementary Material 1. String for MEDLINE Search. 1
- Pharmaceutical Compositions Comprising Prasugrel And
- NVA237 / Glycopyrronium Bromide Multinational, Multi-Database Cohort
- Treprostinil Diethanolamine (Oral Use) for the Treatment of Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension
- Recent Progress and Market Analysis of Anticoagulant Drugs
- Prostaglandin Receptor
- Prostanoid Therapy for Pulmonary Arterial Hypertension David B
- Treprostinil for Protection of Liver Grafts Against Ischemia and Reperfusion Injury During Orthotopic Liver Transplantation - a Translational Study
- Development and Characterization of Treprostinil Palmitil Inhalation Aerosol for the Investigational Treatment of Pulmonary Arterial Hypertension
- Treatment of Pulmonary Arterial Hypertension with Targeted Therapies Dermot S
- The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
- WHO Drug Information Vol 19, No
- Non-Clinical Review(S) Department of Health and Human Services Public Health Service Food and Drug Administration Center for Drug Evaluation and Research
- Biotechnology Corticosteroids & Hormones Synthesis Prostaglandins
- Remodulin Injection (Treprostinil Sodium) 1.0, 2.5, 5.0, and 10 Mg/Ml
- Selective Prostacyclin Receptor Agonist Selexipag, in Contrast to Prostacyclin Analogs, Does Not Evoke Paradoxical Vasoconstriction of the Rat Femoral Artery
- Medicines for Life®
- 2020 Table of Drugs
- Harnessing DNA-Encoded Libraries to Discover Bioactive Small Molecules
- Medimpact April 2019 Specialty Drug List
- Bronchodilation Induced by PGE2 Is Impaired in Group-III Pulmonary Hypertension
- The Second-Generation PGI2 Analogue Treprostinil Fails to Chemoprevent Tumors in a Murine Lung Adenocarcinoma Model Lori Dwyer-Nield1, Gregory A
- The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
- Appendix C - Guidelines for IV Medication Administration
- Do Not Tube List
- Trepulmix, INN-Treprostinil
- Treprostinil Sodium) Injection
- Antiplatelet Therapy – a Pharmacologist’S Perspective
- Pulmonary Arterial Hypertension
- Treprostinil Sodium Procedure No. EMEA/H/C/1115
- Adverse Events of Prostacyclin Mimetics in Pulmonary Arterial Hypertension: a Systematic Review and Meta-Analysis
- Therapy for Pulmonary Arterial Hypertension in Adults Update of the CHEST Guideline and Expert Panel Report
- (12) Patent Application Publication (10) Pub. No.: US 2013/0095095 A1 Lines (43) Pub
- Remodulin (Treprostinil) Injection Is a Sterile Solution of Treprostinil Formulated for Subcutaneous Or Intravenous Administration
- Treprostinil (Remodulin®)
- Medical Policy Statement
- Product List 2020 BIOTECH and FERMENTATION PROSTAGLANDINS CORTICOSTEROIDS & HORMONES SYNTHESIS FRANCOPIA Product Name Business Unit Therapeutic Class ATC4 Page